Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people suffering from preeclampsia (PE) and acute ischemic stroke (AIS). The Company’s lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of pre-eclampsia, acute ischemic stroke and other vascular diseases. DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1 (rhKLK1) in clinical development for preeclampsia and acute ischemic stroke. KLK1 is a serine protease enzyme that is involved in the regulation of diverse physiological processes via a molecular mechanism that increases the production of nitric oxide, prostacyclin and endothelium-derived hyperpolarizing factors. In the treatment of preeclampsia, DM199 is intended to lower blood pressure, enhance endothelial health and improve perfusion to maternal organs and the placenta.
Find out what a historical investment in DiaMedica Therapeutics Inc would be worth today using our DMAC stock calculator.
Buying DMAC shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in DiaMedica Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in DMAC
What is the ticker symbol of DiaMedica Therapeutics Inc?
The ticker symbol for DiaMedica Therapeutics Inc is DMAC.
How much is one share of DMAC?
One share of DMAC is valued at $8.02 as of 20 November 2026.
What is the market capitalisation of DiaMedica Therapeutics Inc DMAC?
As of 20 November 2026 DiaMedica Therapeutics Inc has a market cap of $463.49M.
What is the 52-week high for DiaMedica Therapeutics Inc stock?
The DiaMedica Therapeutics Inc 52-week high stock price is $11.00.
What is the 52-week low for DiaMedica Therapeutics Inc stock?
The DiaMedica Therapeutics Inc 52-week low stock price is $5.25.
Can I buy DMAC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DMAC shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DMAC on Stake
Buy DMAC from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of DMAC from only US$10 with fractional shares